These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24262634)

  • 1. Studying the capability of different cancer hallmarks to initiate tumor growth using a cellular automaton simulation. Application in a cancer stem cell context.
    Monteagudo Á; Santos J
    Biosystems; 2014 Jan; 115():46-58. PubMed ID: 24262634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Analysis in a Cancer Stem Cell Context Using a Tumor Growth Model Based on Cellular Automata.
    Monteagudo Á; Santos J
    PLoS One; 2015; 10(7):e0132306. PubMed ID: 26176702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of behaviour transitions in tumour growth using a cellular automaton simulation.
    Santos J; Monteagudo Á
    IET Syst Biol; 2015 Jun; 9(3):75-87. PubMed ID: 26021328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A logistic cellular automaton for simulating tumor growth].
    Hu R; Ruan X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Mar; 20(1):79-82. PubMed ID: 12744169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria malfunctions as mediators of stem-cells' related carcinogenesis: a hypothesis that supports the highly conserved profile of carcinogenesis.
    Hatzi VI; Terzoudi GI; Pantelias GE; Makropoulos V
    Med Hypotheses; 2013 Jan; 80(1):70-4. PubMed ID: 23111201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational analysis of the influence of the microenvironment on carcinogenesis.
    Basanta D; Ribba B; Watkin E; You B; Deutsch A
    Math Biosci; 2011 Jan; 229(1):22-9. PubMed ID: 21044636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulating the hallmarks of cancer.
    Abbott RG; Forrest S; Pienta KJ
    Artif Life; 2006; 12(4):617-34. PubMed ID: 16953788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New cancer diagnostics and therapeutics from a ninth 'hallmark of cancer': symmetric self-renewal by mutated distributed stem cells.
    Sherley JL
    Expert Rev Mol Diagn; 2013 Nov; 13(8):797-810. PubMed ID: 24151848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells in solid tumors.
    Er O
    Onkologie; 2009 Oct; 32(10):605-9. PubMed ID: 19816080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells in solid tumors: is 'evading apoptosis' a hallmark of cancer?
    Enderling H; Hahnfeldt P
    Prog Biophys Mol Biol; 2011 Aug; 106(2):391-9. PubMed ID: 21473880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryogenesis, morphogens and cancer stem cells: putting the puzzle together.
    Fontana A; Wróbel B
    Med Hypotheses; 2013 Oct; 81(4):643-9. PubMed ID: 23932050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A probability cellular automaton model for hepatitis B viral infections.
    Xiao X; Shao SH; Chou KC
    Biochem Biophys Res Commun; 2006 Apr; 342(2):605-10. PubMed ID: 16487938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis resistance can be used in screening the markers of cancer stem cells.
    Wei C; Guo-min W; Yu-jun L
    Med Hypotheses; 2006; 67(6):1381-3. PubMed ID: 16870354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular automaton simulation examining progenitor hierarchy structure effects on mammary ductal carcinoma in situ.
    Bankhead A; Magnuson NS; Heckendorn RB
    J Theor Biol; 2007 Jun; 246(3):491-8. PubMed ID: 17335852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution and phenotypic selection of cancer stem cells.
    Poleszczuk J; Hahnfeldt P; Enderling H
    PLoS Comput Biol; 2015 Mar; 11(3):e1004025. PubMed ID: 25742563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells: small subpopulation or evolving fraction?
    Enderling H
    Integr Biol (Camb); 2015 Jan; 7(1):14-23. PubMed ID: 25359461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Plasticity and Niche Dynamics in Cancer Progression.
    Picco N; Gatenby RA; Anderson ARA
    IEEE Trans Biomed Eng; 2017 Mar; 64(3):528-537. PubMed ID: 28113244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The meaning of the anti-cancer antibody CLN-IgG (Pritumumab) generated by human × human hybridoma technology against the cyto-skeletal protein, vimentin, in the course of the treatment of malignancy.
    Hugwil AV
    Med Hypotheses; 2013 Sep; 81(3):489-95. PubMed ID: 23856243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion channels and the hallmarks of cancer.
    Prevarskaya N; Skryma R; Shuba Y
    Trends Mol Med; 2010 Mar; 16(3):107-21. PubMed ID: 20167536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ignored hallmarks of carcinogenesis: stem cells and cell-cell communication.
    Trosko JE; Chang CC; Upham BL; Tai MH
    Ann N Y Acad Sci; 2004 Dec; 1028():192-201. PubMed ID: 15650245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.